The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model.
cardiac output
direct Fick
mathematical model
pulmonary hypertension
thermodilution
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
04 Jan 2023
04 Jan 2023
Historique:
received:
06
12
2022
revised:
26
12
2022
accepted:
29
12
2022
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
Background: precapillary pulmonary hypertension (PH, PcPH) is now defined as a mean pulmonary artery pressure (mPAP) > 20 mmHg, a pulmonary artery wedge pressure (PAWP) ≤ 15 mmHg and a pulmonary vascular resistance (PVR) > 2 WU. For PVR calculation, the measurement of cardiac output (CO) is necessary. It is generally measured using thermodilution. However, recent data showed that the agreement with direct Fick method, historically the gold standard, is less than previously reported. We aimed to create a mathematical model that calculated the probability of being classified differently (PcPH or unclassified PH) if CO measured by direct Fick was used instead of thermodilution for any individual patients with a mPAP > 20 mmHg and a PAWP ≤ 15 mmHg. Methods: The model is based on Bland and Altman analysis with a normally distributed difference of cardiac output, fixed 1.96 standard deviation of bias, bias and physiological cardiac output limits. Results: Following a literature review of the studies comparing CO measured with direct Fick and thermodilution, we fixed the 1.96 standard deviation of bias at 2 L/min, bias at 0 L/min and physiological resting CO limits between 1.3 L/min and 10.2 L/min. Conclusions: This model can help the clinician to evaluate the potential benefit of measuring CO using direct Fick during the diagnostic work-up and its utility in confirming or ruling out a diagnosis of PcPH in any given patient with a mPAP > 20 mmHg and a PAWP ≤ 15 mmHg.
Identifiants
pubmed: 36675338
pii: jcm12020410
doi: 10.3390/jcm12020410
pmc: PMC9864355
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pulm Circ. 2022 Jul 01;12(3):e12128
pubmed: 36051350
Int J Cardiol. 2018 May 1;258:228-231
pubmed: 29426632
Circulation. 2019 Aug 20;140(8):705-707
pubmed: 31424987
Am J Respir Crit Care Med. 1999 Aug;160(2):535-41
pubmed: 10430725
Respiration. 2018;96(6):500-506
pubmed: 29428946
Eur Respir J. 2013 Jul;42(1):125-33
pubmed: 23100501
Pulm Circ. 2017 Jan 1;7(1):253-255
pubmed: 28680584
Can Respir J. 2012 Jul-Aug;19(4):261-6
pubmed: 22891186
Respiration. 2021;100(12):1243-1250
pubmed: 34256370
J Cardiovasc Magn Reson. 2008 Nov 05;10:51
pubmed: 18986524
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Congest Heart Fail. 2004 Mar-Apr;10(2 Suppl 2):7-10
pubmed: 15073478
J Clin Med. 2022 May 11;11(10):
pubmed: 35628843
Front Med (Lausanne). 2021 Nov 23;8:776956
pubmed: 34888330
Am J Cardiol. 2014 Feb 1;113(3):546-51
pubmed: 24315114
J Clin Med. 2022 Sep 05;11(17):
pubmed: 36079178
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548